SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-15-000014
Filing Date
2015-05-12
Accepted
2015-05-12 16:05:26
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2015q110qbellicum.htm 10-Q 494991
2 EXHIBIT 10.2 a2015exh102employmentagree.htm EX-10.2 134394
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 14404
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 14398
5 EXHIBIT 32 exhibit32.htm EX-32 11487
  Complete submission text file 0001358403-15-000014.txt   3340217

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blcm-20150331.xml EX-101.INS 374008
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20150331.xsd EX-101.SCH 27541
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20150331_cal.xml EX-101.CAL 40827
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20150331_def.xml EX-101.DEF 85178
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20150331_lab.xml EX-101.LAB 329198
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20150331_pre.xml EX-101.PRE 165771
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 15854467
SIC: 2834 Pharmaceutical Preparations